UrologiiaUrologiiaУрология1728-29852414-9020Bionika Media280101ArticlesСтатьиResearch ArticlePerineal saturation biopsy of the prostateПромежностная сатурационная биопсия простатыSadchenkoA. VСадченкоА. В

Department of Urology

аспирант кафедры урологии

doc.sadchenko@yandex.ruGovorovA. VГоворовА. В

Department of Urology

Кафедра урологии

PushkarD. YuПушкарьД. Ю

Department of Urology

Кафедра урологии

SidorenkovA. VСидоренковА. В

Department of Urology

Кафедра урологии

VasilyevA. OВасильевА. О

Department of Urology

Кафедра урологии

KovylinaM. VКовылинаМ. В

Department of Urology

Кафедра урологии

PrilepskayaE. AПрилепскаяЕ. А

Department of Urology

Кафедра урологии

Moscow State Medical Stomatological University n.a. A.I. EvdokimovМосковский государственный медико-стоматологический университет им. А.И. Евдокимова150220141NO1 (2014)№1 (2014)333625022023Copyright ©; 2014, Bionika MediaCopyright ©; 2014, ООО «Бионика Медиа»2014Bionika MediaООО «Бионика Медиа»https://journals.eco-vector.com/1728-2985/article/view/280101

The effectiveness of perineal biopsy for the detection of prostate cancer (PC) using an array for brachytherapy/cryotherapy was evaluated. It is shown that perineal saturation biopsy provides high detection rate of prostate cancer in patients with suspected cancer after negative transrectal biopsies, does not increase the detection of clinically insignificant cancer and incidence of complications, but requires a lot of time and cost.

Изучена эффективность промежностной биопсии с использованием решетки для брахи/криотерапии в выявлении рака предстательной железы (РПЖ). Показано, что промежностная сатурационная биопсия обеспечивает высокую выявляемость РПЖ среди пациентов с сохраняющимся подозрением на рак после отрицательных трансректальных биопсий, не приводит к увеличению выявляемости клинически незначимого рака и частоты осложнений, однако требует больших временных и финансовых затрат.

prostate biopsyprostate cancerperineal prostate biopsyprostate saturation biopsyбиопсия простатырак простатыпромежностная биопсия простатысатурационная биопсия простатыJemal A., Siegel R., Ward E. et al. Cancer statistics. 2012. CA Cancer J Clin. 2012; 62(1): 10-29.Frankel S., Smith G.D., Donovan J. et al. Screening for prostate cancer. Lancet 2003; 361: 1122-1128.Norberg M., Egevad L., Bolmberg L. et al. The sextant protocol for ultrasound guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997; 50: 562-566.Simon J., Kuefer R., Bartsch G. Jr., et al. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int. 2009; 102: 459-462.Jones J.S. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int. 2007; 99: 1340-1344.Пушкарь Д.Ю., Говоров А.В. Биопсия предстательной железы. М. ГЭОТАР-Медиа., 2010; 208.Djavan B., Ravery V., Zlotta A. et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol. 2001; 166: 1679-1683.Borboroglu P.G., Comer S.W., Riffenburgh R.H. et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000; 163: 158-162.Walz J., Graefen M., Chun F.K. et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur. Urol. 2006; 50: 498-505.Stewart C.S., Leibovich B.C., Weaver A.L. et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001; 166: 86-92.Demura T., Hioka T., Furuno T. et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer. 2005; 103: 1826-1832.Hara R., Jo Y., Fujii T. et al. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy. J Urol. 2008; 71: 191-195.Li H., Yan W., Zhou Y. Transperineal ultrasound- guided saturation biopsies using 11-region template of prostate: report of 303 cases. J Urol. 2007; 70: 1157-1161.Bott S.R., Henderson A., Halls J.E. et al. Extensive transperineal template biopsies of prostate: modifi ed technique and results. J Urol 2006; 68: 1037 -1041.Bott S.R., Henderson A., Parkinson M.C. et al. Setting up a prostate cancer database: experiences on how to get out more than you put in. BJU Int. 2003; 92: 665-666.Novara G., Boscolo-Berto R., Lamon C. et al. Detection rate and factors predictive the presence of prostate cancer in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate. BJU Int. 2010; 105: 1242-1246.Abdollah F., Novara G., Briganti A. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? J Urol. 2011; 77: 921-925.Moran B.J., Braccioforte M.H. Stereotactic transperineal prostate biopsy. J Urol. 2009; 73: 386-388.Bott S.R., Henderson A., McLarty E. et al. A brachytherapy template approach to standardize saturation prostatic biopsy. BJU Int. 2004; 93: 629-630.Barzell W.E., Melamed M.R. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience. J Urol. 2007; 70: 27-35.Onik G., Miessau M., Bostwick D.G. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009; 27: 4321-4326.Taira A.V., Merrick G.S., Galbreath R.W. et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 2010; 13: 71-77.Bittner N., Merrick G.S., Andreini H. et al. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB. J Urol. 2009; 74: 171-176.Jones J.S. Prostate cancer: are we over diagnosing - or under-thinking? Eur. Urol. 2008; 53: 10-12.Fleshner N., Klotz L. Role of “saturation biopsy” in the detection of prostate cancer among diffi cult diagnostic cases. J Urol. 2002; 60: 93-97.Artibani W., Rigatti P., Montorsi F. et al. Transrectal versus transperineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate? J Urol. 2011; 77: 921-925.Merrick G.S., Taubenslag W., Andreini H. et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008; 101(12): 1524-1529.Bittner N., Merrick G.S., Stewart R. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate. Urol. Oncol. 2011; 29(4): 398-404.Patel V., Merrick G.S., Allen Z.A. et al. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning. J Urol. 2011; 77(5): 1148-1152.Pepe P., Aragona F. Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy? Urol. Int. 2011; 87(2): 171-174.Dimmen M., Vlatkovic L., Hole K.H. et al. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU Int. 2012; 110 (2 Pt 2): 69-75.Pal R.P., Elmussareh M., Chanawani M. et al. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies. BJU Int. 2012; 109 (3): 367-371.Gershman B., Zietman A.L., Feldman A.S. et al. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol. Oncol. 2012; Feb 3. [Epub ahead of print].Mabjeesh N.J., Lidawi G., Chen J. et al. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy. BJU Int. 2012; 110 (7): 993-997.Zhang F.B., Shao Q., Du Y. et al. Ultrasound-guided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA № 20 microg/L. Zhonghua Nan Ke Xue 2012; 18(4): 306-309.Bittner N., Merrick G.S., Butler W.M. et al. Incidence And Pathologic Features Of Prostate Cancer Detected On Transperineal Template-Guided Mapping Biopsy Following Negative Transrectal Ultrasound-Guided Biopsy. J Urol. 2013 Feb 14. pii: S0022-5347(13)00290-5. doi: 10.1016/j.juro.2013Symons J.L., Huo A., Yuen C.L. et al. Outcomes of transperineal template-guided prostate biopsy in 409 patients. BJU Int 2013; Apr 3. [Epub ahead of print].Hossack T., Patel M.I., Huo A. et al. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. J Urol. 2012; 188: 781-785.